POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 68 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,675,000 | +73520.3% | 2,500,000 | 0.0% | 0.89% | -15.4% |
| Q2 2023 | $22,650 | +24.6% | 2,500,000 | 0.0% | 1.05% | +17.6% |
| Q1 2023 | $18,175 | -99.9% | 2,500,000 | 0.0% | 0.89% | -7.1% |
| Q4 2022 | $18,225,000 | -5.7% | 2,500,000 | 0.0% | 0.96% | -11.6% |
| Q3 2022 | $19,325,000 | +13.5% | 2,500,000 | 0.0% | 1.09% | +0.8% |
| Q2 2022 | $17,025,000 | -14.6% | 2,500,000 | 0.0% | 1.08% | +5.3% |
| Q1 2022 | $19,925,000 | +42.3% | 2,500,000 | 0.0% | 1.02% | +88.2% |
| Q4 2021 | $14,000,000 | -27.2% | 2,500,000 | 0.0% | 0.54% | -18.9% |
| Q3 2021 | $19,225,000 | – | 2,500,000 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
| Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
| BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
| JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
| PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
| Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
| Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
| Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |